A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.

JAGX Insider Trading (Jaguar Health)

Insider Ownership Percentage: 2.08%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Jaguar Health Insider Trading History Chart

This chart shows the insider buying and selling history at Jaguar Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Jaguar Health Share Price & Price History

Current Price: $0.27
Price Change: +0.30 (1.20%)
As of 08/10/2022 01:00 AM ET

This chart shows the closing price history over time for JAGX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.

Jaguar Health Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/3/2021James J. BochnowskiDirectorSell292$1.75$511.00954,542View SEC Filing Icon  
See Full Table
A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.

SEC Filings (Institutional Ownership Changes) for Jaguar Health (NASDAQ:JAGX)

11.91% of Jaguar Health stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at JAGX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Jaguar Health Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/17/2022Virtu Financial LLC229,270$0.16M0.0%+76.1%0.298%Search for SEC Filing on Google Icon
5/16/2022Goldman Sachs Group Inc.54,770$39K0.0%+153.3%0.071%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC1,522,997$1.08M0.0%N/A1.977%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.1,075,540$0.76M0.0%-41.7%1.396%Search for SEC Filing on Google Icon
5/12/2022Citigroup Inc.47,921$34K0.0%N/A0.062%Search for SEC Filing on Google Icon
5/11/2022Bank of New York Mellon Corp169,749$0.12M0.0%+507.3%0.220%Search for SEC Filing on Google Icon
5/9/2022Principal Financial Group Inc.113,690$81K0.0%-32.7%0.148%Search for SEC Filing on Google Icon
2/9/2022Principal Financial Group Inc.168,908$0.18M0.0%-57.0%0.350%Search for SEC Filing on Google Icon
2/9/2022Buckingham Strategic Wealth LLC32,000$33K0.0%N/A0.066%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC1,055,397$2.40M0.0%-81.1%2.271%Search for SEC Filing on Google Icon
11/12/2021Jump Financial LLC29,666$67K0.0%N/A0.064%Search for SEC Filing on Google Icon
11/12/2021Edmond DE Rothschild Holding S.A.16,666$38K0.0%-66.7%0.036%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.780,110$1.77M0.0%-66.6%1.678%Search for SEC Filing on Google Icon
11/9/2021Principal Financial Group Inc.393,248$0.89M0.0%-67.0%0.846%Search for SEC Filing on Google Icon
11/5/2021Truist Financial Corp29,341$67K0.0%-66.7%0.063%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC2,790,575$4.41M0.0%+193.8%2.001%Search for SEC Filing on Google Icon
8/16/2021State Street Corp395,523$0.63M0.0%N/A0.284%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC5,583,361$8.82M0.0%+6,865.2%4.004%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp230,797$0.37M0.0%+4.4%0.166%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC1,088,159$1.72M0.0%+25.3%0.780%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.5,431,281$8.58M0.0%+188.7%3.895%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.2,334,261$3.69M0.0%+25.4%1.674%Search for SEC Filing on Google Icon
8/10/2021Principal Financial Group Inc.1,191,930$1.88M0.0%N/A0.855%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC28,715$52K0.0%N/A0.022%Search for SEC Filing on Google Icon
5/19/2021Squarepoint Ops LLC64,343$0.12M0.0%N/A0.049%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC949,977$1.71M0.0%+5,815.5%0.731%Search for SEC Filing on Google Icon
5/17/2021Edmond DE Rothschild Holding S.A.50,000$90K0.0%N/A0.038%Search for SEC Filing on Google Icon
5/17/2021Price T Rowe Associates Inc. MD73,000$0.13M0.0%N/A0.056%Search for SEC Filing on Google Icon
5/17/2021HRT Financial LP257,007$0.46M0.0%+1,260.3%0.198%Search for SEC Filing on Google Icon
5/14/2021XTX Topco Ltd38,347$69K0.0%N/A0.029%Search for SEC Filing on Google Icon
5/13/2021Barclays PLC84,154$0.15M0.0%N/A0.065%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC80,161$0.14M0.0%N/A0.062%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp32,019$58K0.0%N/A0.025%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp221,144$0.40M0.0%+267.1%0.170%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC868,667$1.56M0.0%+103.2%0.668%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.1,861,901$3.35M0.0%+1,708,066.1%1.432%Search for SEC Filing on Google Icon
12/11/2020Virtu Financial LLC393,390$0.11M0.0%+560.8%0.488%Search for SEC Filing on Google Icon
10/20/2020Wedbush Securities Inc.115,001$33K0.0%N/A0.143%Search for SEC Filing on Google Icon
9/15/2020Two Sigma Advisers LP50,800$25K0.0%N/A0.063%Search for SEC Filing on Google Icon
8/7/2020Virtu Financial LLC59,529$29K0.0%N/A0.101%Search for SEC Filing on Google Icon
4/17/2020Wedbush Securities Inc.80,831$39K0.0%N/A0.158%Search for SEC Filing on Google Icon
2/4/2020Virtu Financial LLC105,891$85K0.0%N/A0.207%Search for SEC Filing on Google Icon
10/17/2019Wedbush Securities Inc.25,100$33K0.0%N/A0.054%Search for SEC Filing on Google Icon
8/14/2019Invesco Ltd.25,605$0.12M0.0%-98.6%0.510%Search for SEC Filing on Google Icon
7/24/2018Acadian Asset Management LLC99,557$0.14M0.0%N/A1.139%Search for SEC Filing on Google Icon
2/15/2018Sabby Management LLC1,045,741$0.14M0.0%-52.2%1.151%Search for SEC Filing on Google Icon
8/14/2017Kingdon Capital Management L.L.C.1,297,815$0.69M0.0%No Change7.173%Search for SEC Filing on Google Icon
5/15/2017Kingdon Capital Management L.L.C.1,297,815$1.29M0.1%No Change9.265%Search for SEC Filing on Google Icon
2/14/2017Kingdon Capital Management L.L.C.1,297,815$0.92M0.0%+28.7%10.517%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Jaguar Health logo
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The company also develops Crofelemer for multiple possible follow-on indications, including cancer therapy-related diarrhea; orphan-drug indications for symptomatic relief of diarrhea in infants and children with congenital diarrheal disorders and for adult and pediatric patients for short bowel syndrome with intestinal failure with; supportive care for diarrhea relief in inflammatory bowel diseases; diarrhea-predominant irritable bowel syndrome; and for idiopathic/functional diarrhea. In addition, it develops lechlemer, a second-generation anti-secretory agent for cholera; and Canalevia, an oral plant-based drug candidate to treat chemotherapy-induced diarrhea in dogs and exercise-induced diarrhea in dogs. Jaguar Health, Inc. was founded in 2013 and is headquartered in San Francisco, California.
Read More on Jaguar Health

Today's Range

Now: $0.27
Low: $0.27
High: $0.29

50 Day Range

MA: $0.31
Low: $0.25
High: $0.35

52 Week Range

Now: $0.27
Low: $0.25
High: $4.02

Volume

3,881,797 shs

Average Volume

3,302,723 shs

Market Capitalization

$21.83 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.68

Who are the company insiders with the largest holdings of Jaguar Health?

Jaguar Health's top insider investors include:
  1. James J Bochnowski (Director)
Learn More about top insider investors at Jaguar Health.
The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!